• search

Microsoft-B2B launch solution for Pharma industry

Written by: Staff
|

Bangalore, May 12: Microsoft Corporation India Pvt. Ltd. along with B2B Software, a Hyderabad-based Enterprise Solution Company, today rolled out B2B Pharma - a solution for the pharma industry - at a forum organised by the Bulk Drugs Manufacturing Association and Pharmexcil.

Built keeping in mind the challenges faced by the pharma industry, B2B Pharma was an all-in-one solution catering to the complete requirements-including Financial Management, Supply Chain Management as well as manufacturing-of the companies in this Industry, a Microsoft release here said.

The solution was aimed at helping pharma companies align their business processes as well as access the right information required to make the right decisions at the right time. Based on the Microsoft Dynamics Nav platform, the solution was easy to use, easy to implement and custom-made to fit the needs of small manufacturers, distributors, traders in the pharma industry.

Commenting on the launch, Mr Sushant Dwivedy, Business Group Lead - Microsoft Business Solutions, said, ''Companies in the pharma vertical have specialised business requirements such as Shelf Life Management, Quality Tracking and Item Control. B2B pharma offered integrated business applications that will allow small and mid-sized companies in this industry connect employees, customers, and suppliers for improved efficiency. Our partnership with B2B will give us the leading-edge to provide specialized support tailored to our customers as their business grows and their needs evolve.''

UNI

For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more